| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
4 companies
Eli Lilly & Co is a 10% Owner at RNA with holdings across 4 companies. Recent SEC Form 4 filings include 1 buy and 7 sells.
Estimated insider holdings value: $210.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2018 | LLY Eli Lilly & Co | 10% Owner | Sell | 5,752 | $14.31 | $82,333.12 | - | |
| Aug 14, 2018 | LLY Eli Lilly & Co | 10% Owner | Sell | 3,000 | $14.28 | $42,840.00 | - | |
| Aug 13, 2018 | LLY Eli Lilly & Co | 10% Owner | Sell | 6,429 | $14.32 | $92,032.67 | - | |
| Aug 3, 2018 | LLY Eli Lilly & Co | 10% Owner | Sell | 1,650 | $13.55 | $22,357.50 | - | |
| Aug 2, 2018 | LLY Eli Lilly & Co | 10% Owner | Sell | 19,400 | $13.31 | $258,214.00 | -0.5% | |
| Apr 12, 2016 | SYRE Spyre Therapeutics, Inc. | 10% Owner | Buy | 500,000 | $10.00 | $5,000,000.00 | +24.2% |